CIMZIA provides consistent efficacy in a broad range of patients with Crohn's disease and it has been used to treat over 50,000 patients for more than 13 years.
CIMZIA provides consistent efficacy in a broad range of patients with Crohn's disease and it has been used to treat over 50,000 patients for more than 13 years.
CIMZIA provides consistent efficacy in a broad range of patients with Crohn's disease and it has been used to treat over 50,000 patients for more than 13 years.
CIMZIA Rapid Response: Rheumatoid arthritis patients may feel improvement within 1 to 2 weeks after initiation of therapy. Informed Decision: CIMZIA offers the opportunity to make an informed treatment decision within 12 weeks.
Learn about starting CIMZIA® (certolizumab pegol) and CIMZIA® dosing. CIMZIA® injections are for Rheumatoid Arthritis, PSA, CD, and Ankylosing Spondylitis.